Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 62
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Med Microbiol ; 309(6): 151327, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31324525

RESUMEN

A crucial stage of the Streptomyces life cycle is the sporulation septation, a process were dozens of cross walls are synchronously formed in the aerial hyphae in a highly coordinated manner. This process includes the remodeling of the spore envelopes to make Streptomyces spores resistant to detrimental environmental conditions. Sporulation septation and the synthesis of the thickened spore envelope in S. coelicolor A3(2) involves the Streptomyces spore wall synthesizing complex SSSC. The SSSC is a multi-protein complex including proteins directing peptidoglycan synthesis (MreBCD, PBP2, Sfr, RodZ) and cell wall glycopolymer synthesis (PdtA). It also includes two eukaryotic like serin/threonine protein kinases (eSTPK), PkaI and PkaH, which were shown to phosphorylate MreC. Since unbalancing phosphorylation activity by either deleting eSTPK genes or by expressing a second copy of an eSTPK gene affected proper sporulation, a model was developed, in which the activity of the SSSC is controlled by protein phosphorylation.


Asunto(s)
Proteínas Bacterianas/metabolismo , Pared Celular/metabolismo , Streptomyces coelicolor/clasificación , Streptomyces coelicolor/metabolismo , Proteínas Bacterianas/genética , Biopolímeros/química , Biopolímeros/metabolismo , Pared Celular/química , Regulación Bacteriana de la Expresión Génica , Modelos Biológicos , Complejos Multienzimáticos , Peptidoglicano/química , Peptidoglicano/metabolismo , Fosforilación , Esporas Bacterianas/genética , Esporas Bacterianas/metabolismo , Streptomyces coelicolor/genética
2.
Chem Soc Rev ; 44(16): 5793-805, 2015 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-25669838

RESUMEN

Research efforts in the past two decades have resulted in thousands of potential application areas for nanoparticles - which materials have become industrially relevant? Where are sustainable applications of nanoparticles replacing traditional processing and materials? This tutorial review starts with a brief analysis on what makes nanoparticles attractive to chemical product design. The article highlights established industrial applications of nanoparticles and then moves to rapidly emerging applications in the chemical industry and discusses future research directions. Contributions from large companies, academia and high-tech start-ups are used to elucidate where academic nanoparticle research has revolutionized industry practice. A nanomaterial-focused analysis discusses new trends, such as particles with an identity, and the influence of modern instrument advances in the development of novel industrial products.


Asunto(s)
Industrias/métodos , Nanopartículas/química , Estructura Molecular
3.
Toxicol Lett ; 225(1): 20-6, 2014 Feb 10.
Artículo en Inglés | MEDLINE | ID: mdl-24296008

RESUMEN

Quantum dots exhibit extraordinary optical and mechanical properties, and the number of their applications is increasing. In order to investigate a possible effect of coating on the inhalation toxicity of previously tested non-coated CdS/Cd(OH)2 quantum dots and translocation of these very small particles from the lungs, rats were exposed to coated quantum dots or CdCl2 aerosol (since Cd(2+) was present as impurity), 6h/d for 5 consecutive days. Cd content was determined in organs and excreta after the end of exposure and three weeks thereafter. Toxicity was determined by examination of broncho-alveolar lavage fluid and microscopic evaluation of the entire respiratory tract. There was no evidence for translocation of particles from the respiratory tract. Evidence of a minimal inflammatory process was observed by examination of broncho-alveolar lavage fluid. Microscopically, minimal to mild epithelial alteration was seen in the larynx. The effects observed with coated quantum dots, non-coated quantum dots and CdCl2 were comparable, indicating that quantum dots elicited no significant effects beyond the toxicity of the Cd(2+) ion itself. Compared to other compounds with larger particle size tested at similarly low concentrations, quantum dots caused much less pronounced toxicological effects. Therefore, the present data show that small particle sizes with corresponding high surfaces are not the only factor triggering the toxic response or translocation.


Asunto(s)
Compuestos de Cadmio/toxicidad , Glutaral/toxicidad , Hidróxidos/toxicidad , Puntos Cuánticos/toxicidad , Sistema Respiratorio/efectos de los fármacos , Sulfuros/toxicidad , Aerosoles , Animales , Líquido del Lavado Bronquioalveolar , Cloruro de Cadmio/toxicidad , Compuestos de Cadmio/metabolismo , Compuestos de Cadmio/orina , Heces/química , Glutaral/metabolismo , Glutaral/orina , Hidróxidos/metabolismo , Hidróxidos/orina , Exposición por Inhalación , Masculino , Tamaño de la Partícula , Puntos Cuánticos/metabolismo , Ratas , Ratas Wistar , Sistema Respiratorio/metabolismo , Sistema Respiratorio/patología , Sulfuros/metabolismo , Sulfuros/orina , Factores de Tiempo , Distribución Tisular , Pruebas de Toxicidad Aguda
4.
Toxicol Lett ; 208(2): 115-24, 2012 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-22027348

RESUMEN

Colloidal quantum dots (QD) show great promise as fluorescent markers. The QD used in this study were obtained in aqueous medium rather than the widely used colloidal QD. Both methodologies used for the production of QD are associated with the presence of heavy metals such as cadmium (Cd). Here we investigate the short-term inhalation toxicity of water-soluble core-shell CdS/Cd(OH)2 QD. Male Wistar rats were head-nose exposed for 6 h/day on 5 days at the technically maximum concentration (0.52 mg Cd/m³). Histological examination was performed directly after the last exposure. Additional rats were used for Cd organ burden determinations. Clinical parameters in blood, bronchoalveolar lavage fluid and lung tissue were determined 3 days after the last exposure. To analyze the reversibility or progression of effects, the examinations were performed again after a recovery period of 3 weeks. The results of the study indicate that CdS/Cd(OH)2 QD caused local neutrophil inflammation in the lungs that partially regressed after the 3-week recovery period. There was no evidence that QD were translocated to the central nervous system nor that a systemic acute phase response occurred.


Asunto(s)
Compuestos de Cadmio/toxicidad , Pulmón/efectos de los fármacos , Sulfuros/toxicidad , Aerosoles , Animales , Compuestos de Cadmio/administración & dosificación , Inflamación/inducido químicamente , Exposición por Inhalación , Masculino , Microscopía Electrónica de Transmisión , Neutrófilos/efectos de los fármacos , Puntos Cuánticos , Ratas , Ratas Wistar , Sulfuros/administración & dosificación , Distribución Tisular
5.
Adv Exp Med Biol ; 696: 3-15, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21431541

RESUMEN

Streptomyces coelicolor, the model species of the genus Streptomyces, presents a complex life cycle of successive morphological and biochemical changes involving the formation of substrate and aerial mycelium, sporulation and the production of antibiotics. The switch from primary to secondary metabolism can be triggered by nutrient starvation and is of particular interest as some of the secondary metabolites produced by related Streptomycetes are commercially relevant. To understand these events on a molecular basis, a reliable technical platform encompassing reproducible fermentation as well as generation of coherent transcriptomic data is required. Here, we investigate the technical basis of a previous study as reported by Nieselt et al. (BMC Genomics 11:10, 2010) in more detail, based on the same samples and focusing on the validation of the custom-designed microarray as well as on the reproducibility of the data generated from biological replicates. We show that the protocols developed result in highly coherent transcriptomic measurements. Furthermore, we use the data to predict chromosomal gene clusters, extending previously known clusters as well as predicting interesting new clusters with consistent functional annotations.


Asunto(s)
Perfilación de la Expresión Génica/estadística & datos numéricos , Análisis de Secuencia por Matrices de Oligonucleótidos/estadística & datos numéricos , Streptomyces coelicolor/genética , Streptomyces coelicolor/metabolismo , Técnicas Bacteriológicas , Fermentación , Genes Bacterianos , Familia de Multigenes , Reproducibilidad de los Resultados , Programas Informáticos , Streptomyces coelicolor/crecimiento & desarrollo
6.
J Biotechnol ; 140(1-2): 13-7, 2009 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-19297688

RESUMEN

Bacterial secondary metabolites are an important source of antimicrobial and cytostatic drugs. These molecules are often synthesized in a stepwise fashion by multimodular megaenzymes that are encoded in clusters of genes encoding enzymes for precursor supply and modification. In this work,we present an open source software pipeline, CLUSEAN (CLUster SEquence ANalyzer) that helps to annotate and analyze such gene clusters. CLUSEAN integrates standard analysis tools, like BLAST and HMMer, with specific tools for the identification of the functional domains and motifs in nonribosomal peptide synthetases (NRPS)/type I polyketide synthases (PKS) and the prediction of specificities of NRPS.


Asunto(s)
Bacterias/genética , Genes Bacterianos , Macrólidos/metabolismo , Familia de Multigenes , Sintasas Poliquetidas , Programas Informáticos , Antibacterianos/metabolismo , Bacterias/metabolismo , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Simulación por Computador , Bases de Datos Genéticas , Biosíntesis de Péptidos Independientes de Ácidos Nucleicos , Sintasas Poliquetidas/química , Sintasas Poliquetidas/genética , Sintasas Poliquetidas/metabolismo , Estructura Terciaria de Proteína/genética
7.
Antimicrob Agents Chemother ; 52(5): 1686-96, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18285472

RESUMEN

Phosphinothricin tripeptide (PTT) is a peptide antibiotic produced by Streptomyces viridochromogenes Tü494, and it is synthesized by nonribosomal peptide synthetases. The PTT biosynthetic gene cluster contains three peptide synthetase genes: phsA, phsB, and phsC. Each of these peptide synthetases comprises only one module. In neither PhsB nor PhsC is a typical C-terminal thioesterase domain present. In contrast, a single thioesterase GXSXG motif has been identified in the N terminus of the first peptide synthetase, PhsA. In addition, two external thioesterase genes, theA and theB, are located within the PTT biosynthetic gene cluster. To analyze the thioesterase function as well as the assembly of the peptide synthetases within PTT biosynthesis, several mutants were generated and analyzed. A phsA deletion mutant (MphsA) was complemented with two different phsA constructs that were carrying mutations in the thioesterase motif. In one construct, the thioesterase motif comprising 45 amino acids of phsA were deleted. In the second construct, the conserved serine residue of the GXSXG motif was replaced by an alanine. In both cases, the complementation of MphsA did not restore PTT biosynthesis, revealing that the thioesterase motif in the N terminus of PhsA is required for PTT production. In contrast, TheA and TheB might have editing functions, as an interruption of the theA and theB genes led to reduced PTT production, whereas an overexpression of both genes in the wild type enhanced the PTT yield. The presence of an active single thioesterase motif in the N terminus of PhsA points to a novel mechanism of product release.


Asunto(s)
Proteínas Bacterianas/metabolismo , Compuestos Organofosforados/metabolismo , Péptido Sintasas/metabolismo , Streptomyces/enzimología , Proteínas Bacterianas/genética , Prueba de Complementación Genética , Immunoblotting , Modelos Biológicos , Estructura Molecular , Mutagénesis Sitio-Dirigida , Mutación , Compuestos Organofosforados/química , Péptido Sintasas/genética , Reacción en Cadena de la Polimerasa , Streptomyces/genética , Streptomyces/metabolismo , Tioléster Hidrolasas/genética , Tioléster Hidrolasas/metabolismo
8.
Appl Microbiol Biotechnol ; 77(1): 125-34, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17823795

RESUMEN

All known gene clusters for glycopeptide antibiotic biosynthesis contain a conserved gene supposed to encode an ABC-transporter. In the balhimycin-producer Amycolatopsis balhimycina this gene (tba) is localised between the prephenate dehydrogenase gene pdh and the peptide synthetase gene bpsA. Inactivation of tba in A. balhimycina by gene replacement did not interfere with growth and did not affect balhimycin resistance. However, in the supernatant of the tba mutant RM43 less balhimycin was accumulated compared to the wild type; and the intra-cellular balhimycin concentration was ten times higher in the tba mutant RM43 than in the wild type. These data suggest that the ABC transporter encoded in the balhimycin biosynthesis gene cluster is not involved in resistance but is required for the efficient export of the antibiotic. To elucidate the activity of Tba it was heterologously expressed in Escherichia coli with an N-terminal His-tag and purified by nickel chromatography. A photometric assay revealed that His(6)-Tba solubilised in dodecylmaltoside possesses ATPase activity, characteristic for ABC-transporters.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/fisiología , Actinomycetales/metabolismo , Proteínas Bacterianas/fisiología , Vancomicina/análogos & derivados , Transportadoras de Casetes de Unión a ATP/genética , Transportadoras de Casetes de Unión a ATP/metabolismo , Actinomycetales/genética , Secuencia de Aminoácidos , Antibacterianos/metabolismo , Antibacterianos/farmacocinética , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Transporte Biológico/efectos de los fármacos , Southern Blotting , Farmacorresistencia Bacteriana , Electroforesis en Gel de Poliacrilamida , Glicopéptidos/metabolismo , Glicopéptidos/farmacocinética , Glicopéptidos/farmacología , Datos de Secuencia Molecular , Mutación , Reacción en Cadena de la Polimerasa , Estructura Secundaria de Proteína , Vancomicina/metabolismo , Vancomicina/farmacocinética , Vancomicina/farmacología
9.
Antimicrob Agents Chemother ; 51(3): 1028-37, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17220414

RESUMEN

Actinoplanes friuliensis produces the lipopeptide antibiotic friulimicin, which is a cyclic peptide with one exocyclic amino acid linked to a branched-chain fatty acid acyl residue. The structural relationship to daptomycin and the excellent antibacterial performance of friulimicin make the antibiotic an attractive drug candidate. The complete friulimicin biosynthetic gene cluster of 24 open reading frames from A. friuliensis was sequenced and analyzed. In addition to genes for regulation, self-resistance, and transport, the cluster contains genes encoding peptide synthetases, proteins involved in the synthesis and linkage of the fatty acid component of the antibiotic, and proteins involved in the synthesis of the nonproteinogenic amino acids pipecolinic acid, methylaspartic acid, and 2,3-diaminobutyric acid. By using heterologous gene expression in Escherichia coli, we provide biochemical evidence for the stereoselective synthesis of L-pipecolinic acid by the deduced protein of the lysine cyclodeaminase gene pip. Furthermore, we show the involvement of the dabA and dabB genes in the biosynthesis of 2,3-diaminobutyric acid by gene inactivation and subsequent feeding experiments.


Asunto(s)
Antibacterianos/biosíntesis , Micromonosporaceae/genética , Micromonosporaceae/metabolismo , Aminobutiratos/metabolismo , Southern Blotting , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Conjugación Genética , ADN Bacteriano/genética , ADN Bacteriano/metabolismo , Electroforesis en Gel de Poliacrilamida , Escherichia coli/metabolismo , Prueba de Complementación Genética , Hibridación in Situ , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Familia de Multigenes , Mutación/genética , Mutación/fisiología , Ácidos Pipecólicos/metabolismo , Plásmidos/genética
10.
Arch Microbiol ; 186(6): 447-58, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16932908

RESUMEN

Streptomyces coelicolor A3(2) has three additional glnA-type genes besides the glutamine synthetase genes glnA (encoding GSI) and glnII (encoding GSII). The aim of this work was to characterize their functional properties and regulation. Sequence analyses revealed that GlnA2, GlnA3, and GlnA4 are dissimilar to S. coelicolor GSI and lack highly conserved amino acid residues involved in catalysis. In heterologous expression experiments, glnA2, glnA3, and glnA4, in contrast to glnA and glnII, were not capable of complementing the L-glutamine auxotrophy of an Escherichia coli glnA mutant. The lack of a conserved sequence motif reflecting adenylylation control of enzyme activity suggests that GlnA2, GlnA3, and GlnA4 are not regulated via adenylyltransferase-mediated modification. In DNA-binding assays, the OmpR-like regulator of nitrogen metabolism GlnRII, which interacts with the glnA and glnII promoters, did not bind to the upstream regions of glnA2, glnA3, and glnA4. These findings support the conclusion that glnA2, glnA3, and glnA4 are not directly involved in L-glutamine synthesis and nitrogen assimilation and are not subject to nitrogen control in S. coelicolor. The glnA3 gene product is similar to FluG, which is required for asexual sporulation in Aspergillus nidulans. However, inactivation of glnA3 does not block morphological differentiation in S. coelicolor.


Asunto(s)
Glutamato-Amoníaco Ligasa/genética , Streptomyces coelicolor/genética , Secuencia de Aminoácidos , Regulación Bacteriana de la Expresión Génica , Genes Bacterianos , Datos de Secuencia Molecular , Alineación de Secuencia , Streptomyces coelicolor/enzimología
12.
Appl Microbiol Biotechnol ; 63(4): 344-50, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14564489

RESUMEN

Glycopeptide antibiotics are a class of widely known natural compounds produced by Actinomycetes. Vancomycin, the first member of the glycopeptide family to be discovered, was described in 1955 and used as an antibiotic soon thereafter. During the past 50 years numerous contributions on the structure, mode of action, and therapeutic features of vancomycin have been published. Recently, there has been considerable progress in elucidating the biosynthesis of glycopeptide antibiotics by combining molecular biology and analytical chemistry methods. Here, we provide an overview of the current knowledge regarding biosynthetic glycopeptide assembly.


Asunto(s)
Actinobacteria/genética , Actinobacteria/metabolismo , Antibacterianos/biosíntesis , Antibacterianos/química , Vancomicina/análogos & derivados , Aminoácidos Aromáticos/biosíntesis , Péptido Sintasas/genética , Péptido Sintasas/metabolismo , Teicoplanina/biosíntesis , Teicoplanina/química , Vancomicina/biosíntesis , Vancomicina/química
13.
J Biotechnol ; 106(2-3): 221-32, 2003 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-14651864

RESUMEN

Streptomycetes are the most important bacterial producers of bioactive secondary metabolites such as antibiotics or cytostatics. Due to the emerging resistance of pathogenic bacteria to all commonly used antibiotics, new and modified natural compounds are required for the development of novel drugs. In addition to the classical screening for natural compounds, genome driven approaches like combinatorial biosynthesis are permanently gaining relevance for the generation of new structures. This technology utilizes the combination of genes from different biosynthesis pathways resulting in the production of novel or modified metabolites. The basis for this strategy is the access to a significant number of genes and the knowledge about the activity and specificity of the enzymes encoded by them. A joint initiative was started to exploit the biosynthesis gene clusters from streptomycetes. In this publication, an overview of the strategy for the identification and characterization of numerous biosynthesis gene clusters for polyketides displaying interesting functions and particular structural features is given.


Asunto(s)
Antibacterianos/biosíntesis , Técnicas Químicas Combinatorias/métodos , Regulación Bacteriana de la Expresión Génica/fisiología , Ingeniería Genética/métodos , Macrólidos/metabolismo , Streptomyces/genética , Streptomyces/metabolismo , Especificidad de la Especie , Streptomyces/clasificación
14.
Antimicrob Agents Chemother ; 47(2): 447-57, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12543643

RESUMEN

Actinoplanes friuliensis produces the lipopeptide antibiotic friulimicin. This antibiotic is active against gram-positive bacteria such as multiresistant Enterococcus and Staphylococcus strains. It consists of 10 amino acids that form a ring structure and 1 exocyclic amino acid to which an acyl residue is attached. By a reverse genetic approach, biosynthetic genes were identified that are required for the nonribosomal synthesis of the antibiotic. In close proximity two genes (glmA and glmB) were found which are involved in the production of methylaspartate, one of the amino acids of the peptide core. Methylaspartate is synthesized by a glutamate mutase mechanism, which was up to now only described for glutamate fermentation in Clostridium sp. or members of the family ENTEROBACTERIACEAE: The active enzyme consists of two subunits, and the corresponding genes overlap each other. To demonstrate enzyme activity in a heterologous host, it was necessary to genetically fuse glmA and glmB. The resulting gene was overexpressed in Streptomyces lividans, and the fusion protein was purified in an active form. For gene disruption mutagenesis, a host-vector system was established which enables genetic manipulation of Actinoplanes spp. for the first time. Thus, targeted inactivation of biosynthetic genes was possible, and their involvement in friulimicin biosynthesis was demonstrated.


Asunto(s)
Antibacterianos/biosíntesis , Transferasas Intramoleculares/genética , Péptidos , Secuencia de Aminoácidos , Antibacterianos/química , Transferasas Intramoleculares/metabolismo , Plásmidos
15.
Mol Microbiol ; 46(2): 319-30, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12406211

RESUMEN

Glutamine synthetase I (GSI) enzyme activity in Streptomyces coelicolor is controlled post-translationally by the adenylyltransferase (GlnE) as in enteric bacteria. Although other homologues of the Escherichia coli Ntr system (glnK, coding for a PII family protein; and glnD, coding for an uridylyltransferase) are found in the S. coelicolor genome, the regulation of the GSI activity was found to be different. The functions of glnK and glnD were analysed by specific mutants. Surprisingly, biochemical assay and two-dimensional PAGE analysis showed that modification of GSI by GlnE occurs normally in all mutant strains, and neither GlnK nor GlnD are required for the regulation of GlnE in response to nitrogen stimuli. Analysis of the post-translational regulation of GlnK in vivo by two-dimensional PAGE and mass spectrometry indicated that it is subject to both a reversible and a non-reversible modification in a direct response to nitrogen availability. The irreversible modification was identified as removal of the first three N-terminal amino acid residues of the protein, and the reversible modification as adenylylation of the conserved tyro-sine 51 residue that is known to be uridylylated in E. coli. The glnD insertion mutant expressing only the N-terminal half of GlnD was capable of adenylylating GlnK, but was unable to perform the reverse deadenylylation reaction in response to excess ammonium. The glnD null mutant completely lacked the ability to adenylylate GlnK. This work provides the first example of a PII protein that is modified by adenylylation, and demonstrates that this reaction is performed by a homologue of GlnD, previously described only as a uridylyltransferase enzyme.


Asunto(s)
Proteínas Bacterianas , Proteínas Portadoras/metabolismo , Escherichia coli/enzimología , Nucleotidiltransferasas/metabolismo , Streptomyces/enzimología , Secuencia de Aminoácidos , Proteínas Portadoras/química , Proteínas Portadoras/genética , ADN Bacteriano/análisis , Electroforesis en Gel Bidimensional , Escherichia coli/genética , Regulación Bacteriana de la Expresión Génica , Glutamato-Amoníaco Ligasa/metabolismo , Datos de Secuencia Molecular , Mutación , Nitrógeno/metabolismo , Nucleotidiltransferasas/química , Nucleotidiltransferasas/genética , Proteínas PII Reguladoras del Nitrógeno , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Transducción de Señal , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Streptomyces/genética
16.
Mol Microbiol ; 46(2): 331-47, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12406212

RESUMEN

Streptomyces coelicolor has an unusually large arsenal of glutamine synthetase (GS) enzymes: a prokaryotic GSI-beta-subtype enzyme (encoded by glnA), three annotated glnA-like genes of the GSI-alpha-subtype and a eukaryote-like glutamine synthetase II (encoded by glnII). Under all tested conditions, GSI was found to represent the dominant glutamine synthetase activity. A significant heat-labile GSII activity, which is very low to undetectable in liquid-grown cultures, was only detected in morphologically differentiating S. coelicolor cultures. Analysis of glnA and glnII transcription by S1 nuclease mapping and egfp fusions revealed that, on nitrogen-limiting solid medium, glnII but not glnA expression is upregulated. An OmpR-like regulator protein, GlnR, has previously been implicated in transcriptional control of glnA expression. Gel retardation analysis revealed that GlnR is a DNA-binding protein, which interacts with the glnA promoter. It is not autoregulatory and does not bind to the upstream regions of the glnA-like genes of the alpha-subfamily, nor to the glnII promoter in vitro. A second GlnR target was identified upstream of the amtB gene, encoding a putative ammonium transporter. amtB forms an operon with glnK (encoding a PII protein) and glnD (encoding a putative PII nucleotidylyltransferase) shown by S1 nuclease protection analysis and reverse transcription-polymerase chain reaction (RT-PCR). An amtB and glnA promoter alignment revealed a putative GlnR operator structure. Downstream of glnII, a gene encoding for another OmpR-like regulator, GlnRII, was identified, with strong similarity to GlnR. Gel shifts with GlnRII showed that the promoters recognized by GlnR are also targets of GlnRII. However, GlnRII also interacted with the glnII upstream region. Only inactivation of glnR resulted in a glutamine auxotrophic phenotype, whereas the glnRII mutant can grow on minimal medium without glutamine.


Asunto(s)
Proteínas Bacterianas/metabolismo , Proteínas de Unión al ADN , Regulación Bacteriana de la Expresión Génica , Nitrógeno/metabolismo , Streptomyces/metabolismo , Transactivadores/metabolismo , Secuencia de Aminoácidos , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Secuencia de Bases , Eliminación de Gen , Glutamato-Amoníaco Ligasa/química , Glutamato-Amoníaco Ligasa/genética , Glutamato-Amoníaco Ligasa/metabolismo , Datos de Secuencia Molecular , Regiones Operadoras Genéticas , Regiones Promotoras Genéticas , Alineación de Secuencia , Streptomyces/genética , Transactivadores/química , Transactivadores/genética , Transcripción Genética
17.
J Biotechnol ; 92(2): 195-204, 2001 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-11640989

RESUMEN

For the first time gene cloning systems have been developed for Amycolatopsis japonicum. Direct transformation, polyethyleneglycol (PEG) induced protoplast transformation and conjugal transfer was established for A. japonicum MG417-CF17, the ethylenediaminedisuccinic acid (EDDS) producer. The direct transformation procedure was modified to introduce DNA. The most important parameter for an efficient DNA uptake was the age of the culture. Using of mycelium from 36-h old cultures resulted in the highest transformation frequencies. Further, conditions for transformation of A. japonicum protoplasts were established. The efficiency of transformation depended mainly on the source of PEG and the components of the regeneration agar. The replicative plasmid pULVK2A carrying pA-rep and the apramycin resistance gene was transferred into the EDDS producer with a frequency of 0.38 colonies microg(-1) DNA by using the direct transformation procedure and with a frequency of 0.56 colonies microg(-1) DNA by using the PEG induced protoplast transformation. The plasmid was genetically stable, and could easily be reisolated from A. japonicum. We also demonstrated that conjugal transfer of the plasmid pSET152 from Escherichia coli ET12567 (pUB307) to Amycolatopsis spores is possible. The plasmid pSET152 integrated in the A. japonicum chromosome. A titre of 2.4 x 10(-4) exconjugants per recipient was obtained.


Asunto(s)
Actinomycetales/genética , Actinomycetales/metabolismo , Clonación Molecular/métodos , Etilenodiaminas/metabolismo , Genes Bacterianos , Succinatos/metabolismo , Actinomycetales/efectos de los fármacos , Bacteriófagos/genética , Secuencia de Bases , Biotecnología , Conjugación Genética , ADN Bacteriano/genética , Farmacorresistencia Bacteriana/genética , Escherichia coli/genética , Plásmidos/genética , Polietilenglicoles , Transformación Genética
18.
Anal Chem ; 73(17): 4313-8, 2001 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-11569825

RESUMEN

This paper describes the design, characterization, and use of an optical biosensor suited for the process control of biotechnological processes. The detector principle is based on reflectometric interference spectroscopy (RIfS). RIfS enables a label-free, product-specific monitoring, with a future outline for on-line process control. The potential of the RIfS biosensor is exemplified by the qualitative and quantitative monitoring of the microbial production of vancomycin-type glycopeptide antibiotics.


Asunto(s)
Antibacterianos/análisis , Actinomycetales/metabolismo , Antibacterianos/biosíntesis , Técnicas Biosensibles , Cromatografía Líquida de Alta Presión , Fermentación , Luz , Músculo Liso , Péptidos/síntesis química
19.
J Biol Chem ; 276(42): 38370-7, 2001 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-11495926

RESUMEN

Balhimycin, a vancomycin-type antibiotic from Amycolatopsis mediterranei, contains the unusual amino acid (S)-3,5-dihydroxyphenylglycine (Dpg), with an acetate-derived carbon backbone. After sequence analysis of the biosynthetic gene cluster, one gene, dpgA, for a predicted polyketide synthase (PKS) was identified, sharing 20-30% identity with plant chalcone synthases. Inactivation of dpgA resulted in loss of balhimycin production, and restoration was achieved by supplementation with 3,5-dihydroxyphenylacetic acid, which is both a possible product of a PKS reaction and a likely precursor of Dpg. Enzyme assays with the protein expressed in Streptomyces lividans showed that this PKS uses only malonyl-CoA as substrate to synthesize 3,5-dihydroxyphenylacetic acid. The PKS gene is organized in an operon-like structure with three downstream genes that are similar to enoyl-CoA-hydratase genes and a dehydrogenase gene. The heterologous co-expression of all four genes led to accumulation of 3,5-dihydroxyphenylglyoxylic acid. Therefore, we now propose a reaction sequence. The final step in the pathway to Dpg is a transamination. A predicted transaminase gene was inactivated, resulting in abolished antibiotic production and accumulation of 3,5-dihydroxyphenylglyoxylic acid. Interestingly, restoration was only possible by simultaneous supplementation with (S)-3,5-dihydroxyphenylglycine and (S)-4-hydroxyphenylglycine, indicating that the transaminase is essential for the formation of both amino acids.


Asunto(s)
Proteínas Bacterianas , Coenzima A Ligasas/química , Coenzima A Ligasas/genética , Antagonistas de Aminoácidos Excitadores/química , Glicina/biosíntesis , Glicina/química , Complejos Multienzimáticos/química , Complejos Multienzimáticos/metabolismo , Resorcinoles/química , Vancomicina/análogos & derivados , Aminoácidos/biosíntesis , Cromatografía Líquida de Alta Presión , Coenzima A Ligasas/biosíntesis , Eliminación de Gen , Glicina/análogos & derivados , Glicopéptidos/biosíntesis , Modelos Químicos , Modelos Genéticos , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Plásmidos/metabolismo , Análisis de Secuencia de ADN , Streptomyces/enzimología , Vancomicina/biosíntesis
20.
Appl Environ Microbiol ; 67(8): 3603-9, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11472937

RESUMEN

Streptomyces viridochromogenes Tü494 produces the antibiotic phosphinothricin tripeptide (PTT). In the postulated biosynthetic pathway, one reaction, the isomerization of phosphinomethylmalate, resembles the aconitase reaction of the tricarboxylic acid (TCA) cycle. It was speculated that this reaction is carried out by the corresponding enzyme of the primary metabolism (C. J. Thompson and H. Seto, p. 197-222, in L. C. Vining and C. Stuttard, ed., Genetics and Biochemistry of Antibiotic Production, 1995). However, in addition to the TCA cycle aconitase gene, a gene encoding an aconitase-like protein (the phosphinomethylmalate isomerase gene, pmi) was identified in the PTT biosynthetic gene cluster by Southern hybridization experiments, using oligonucleotides which were derived from conserved amino acid sequences of aconitases. The deduced protein revealed high similarity to aconitases from plants, bacteria, and fungi and to iron regulatory proteins from eucaryotes. Pmi and the S. viridochromogenes TCA cycle aconitase, AcnA, have 52% identity. By gene insertion mutagenesis, a pmi mutant (Mapra1) was generated. The mutant failed to produce PTT, indicating the inability of AcnA to carry out the secondary-metabolism reaction. A His-tagged protein (Hispmi*) was heterologously produced in Streptomyces lividans. The purified protein showed no standard aconitase activity with citrate as a substrate, and the corresponding gene was not able to complement an acnA mutant. This indicates that Pmi and AcnA are highly specific for their respective enzymatic reactions.


Asunto(s)
Aconitato Hidratasa/genética , Aminobutiratos/metabolismo , Proteínas Bacterianas , Hidroliasas/genética , Hidroliasas/farmacología , Streptomyces/enzimología , Aconitato Hidratasa/metabolismo , Aminobutiratos/química , ADN Intergénico/genética , Prueba de Complementación Genética , Malatos/metabolismo , Datos de Secuencia Molecular , Familia de Multigenes , Mutagénesis Insercional , Compuestos Organofosforados/metabolismo , Péptidos/metabolismo , Regiones Promotoras Genéticas/genética , Análisis de Secuencia de ADN , Streptomyces/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA